KorAP: Find »[drukola/base=of & drukola/pos=noun]« with Poliqarp

<1 ...380 381 382 ...1827 >

45,651 matches

Corola-llms4eu/Law/285165

P Young.Status of organised screening programs with FIT around the world.CRC SC Viena IFCC FIT working group update .Sally C Benton on behalf of the IFCC FIT working group Hewitson P, Glasziou P, Watson E, et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol.2008;103:1541-1549. Allison JE, Tekawa IS, Ransom LJ, et al. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med. 1996;334:155-159. Young GP, St

ANEXE din 28 iunie 2024 (2024) [Corola-llms4eu/Law/285165]
FIT working group Hewitson P, Glasziou P, Watson E, et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol.2008;103:1541-1549. Allison JE, Tekawa IS, Ransom LJ, et al. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med. 1996;334:155-159. Young GP, St John DJ, Rose IS, et al. Haem in the gut. Part II.Faecal excretion of haem and haem-derived porphyrins and their detection. J Gastroenterol Hepatol. 1990;5:194-203 Robertson

ANEXE din 28 iunie 2024 (2024) [Corola-llms4eu/Law/285165]
J Gastroenterol.2008;103:1541-1549. Allison JE, Tekawa IS, Ransom LJ, et al. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med. 1996;334:155-159. Young GP, St John DJ, Rose IS, et al. Haem in the gut. Part II.Faecal excretion of haem and haem-derived porphyrins and their detection. J Gastroenterol Hepatol. 1990;5:194-203 Robertson, Douglas J. et al.Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology, Volume 152

ANEXE din 28 iunie 2024 (2024) [Corola-llms4eu/Law/285165]
152, Issue 5, 1217 - 1237.e3 Zorzi M, Fedeli U, Schievano E, et al. Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test. Gut 2015;64:784-90. Chiang TH, Chuang SL, Chen SL, et al. Difference in performance of fecal immunochemical tests with the same hemoglobin cutoff concentration in a nationwide colorectal cancer screening program. Gastroenterology 2014;147:1317-26. Lee JK, Liles EG, Bent S, et al. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern

ANEXE din 28 iunie 2024 (2024) [Corola-llms4eu/Law/285165]
Med 2014;160:171. Fraser CG, Allison JE, Halloran SP, et al. A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin. J Natl Cancer Inst 2012;104:810-4.Open 2019;9:e032773. doi: 10.1136/bmjopen-2019-032773 Gies A, Cuk K, Schrotz-King P, Brenner H. Combination of Different Fecal Immunochemical Tests in Colorectal Cancer Screening: Any Gain in Diagnostic Performance?. Cancers (Basel). 2019;11(1):120. Published 2019 Jan 20. doi:10.3390/cancers11010120 Ribbing Wilen, H., Blom, J., Hoijer, J., and Hultcrantz, R. ( 2019) Fecal immunochemical test in colorectal cancer screening: Colonoscopy

ANEXE din 28 iunie 2024 (2024) [Corola-llms4eu/Law/285165]
Cancer Screening: Any Gain in Diagnostic Performance?. Cancers (Basel). 2019;11(1):120. Published 2019 Jan 20. doi:10.3390/cancers11010120 Ribbing Wilen, H., Blom, J., Hoijer, J., and Hultcrantz, R. ( 2019) Fecal immunochemical test in colorectal cancer screening: Colonoscopy findings by different cut-off levels. Journal of Gastroenterology and Hepatology, 34: 103- 112. https://doi.org/10.1111/jgh.14373. Doubeni CA, Jensen CD, Fedewa SA, et al. Fecal Immunochemical Test (FIT) for Colon Cancer Screening: Variable Performance with Ambient Temperature. J Am Board Fam Med. 2016;29(6):672-681. doi:10.3122/jabfm.2016.06.160060 Zorzi M, Fedato

ANEXE din 28 iunie 2024 (2024) [Corola-llms4eu/Law/285165]
Doubeni CA, Jensen CD, Fedewa SA, et al. Fecal Immunochemical Test (FIT) for Colon Cancer Screening: Variable Performance with Ambient Temperature. J Am Board Fam Med. 2016;29(6):672-681. doi:10.3122/jabfm.2016.06.160060 Zorzi M, Fedato C, Grazzini G, et al. High sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region, Italy.Gut 2011;60:944-949 Guidelines for Quality Assurance in Colorectal Cancer Screening programmes. Published 2012. ISBN 978-1-907487-07-1 Tinmouth J, Kennedy EB, Baron D, et al. Colonoscopy quality assurance in Ontario

ANEXE din 28 iunie 2024 (2024) [Corola-llms4eu/Law/285165]
clinical practice guideline. Can J Gastroenterol Hepatol. 2014;28(5):251-274. doi:10.1155/2014/262816 Senore C, Inadomi J, Segnan N, et al. Optimising colorectal cancer screening acceptance: a review. Gut 2015;64:1158-1177. Gill MD, Bramble MG, Rees CJ, Lee TJ, Bradburn DM, Mills SJ. Comparison of screen-detected and interval colorectal cancers in the Bowel Cancer Screening Programme. Br J Cancer. 2012;107(3):417-421. doi:10.1038/bjc.2012.305 Screening programmes: a short guide. Increase effectiveness, maximize benefits and minimize harm. Copenhagen: WHO Regional Office for Europe; 2020 (https://apps.who.int/iris/ handle/10665/330829). Anexa

ANEXE din 28 iunie 2024 (2024) [Corola-llms4eu/Law/285165]
Corola-llms4eu/Law/285272

pp. 448-458 Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, Wiener H, Herbert A, Daniel J, & von Karsa L (eds.). (2008). European guidelines for quality assurance in cervical cancer screening - second edition. Office for Official Publications of the European Communities, Luxembourg. Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R & Peto J (2012). Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine, vol. 30 Suppl

METODOLOGIE din 28 iunie 2024 (2024) [Corola-llms4eu/Law/285272]
second edition. Office for Official Publications of the European Communities, Luxembourg. Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R & Peto J (2012). Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine, vol. 30 Suppl 5, pp. F88-F99 Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, Tortolero-Luna G, Kjaer SK & Munoz N (2008). Epidemiology and natural history of human papillomavirus infections and type

METODOLOGIE din 28 iunie 2024 (2024) [Corola-llms4eu/Law/285272]
papillomavirus testing in secondary prevention of cervical cancer. Vaccine, vol. 30 Suppl 5, pp. F88-F99 Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, Tortolero-Luna G, Kjaer SK & Munoz N (2008). Epidemiology and natural history of human papillomavirus infections and type specific implications in cervical neoplasia. Vaccine, vol. 26 Suppl 10, pp. K1-16 Commission of the European Communities (2008). Report from the Commission to the Council, the European Parliament, the European Economic and Social Committee and

METODOLOGIE din 28 iunie 2024 (2024) [Corola-llms4eu/Law/285272]
AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, Tortolero-Luna G, Kjaer SK & Munoz N (2008). Epidemiology and natural history of human papillomavirus infections and type specific implications in cervical neoplasia. Vaccine, vol. 26 Suppl 10, pp. K1-16 Commission of the European Communities (2008). Report from the Commission to the Council, the European Parliament, the European Economic and Social Committee and the Committee of the Regions - Implementation of the Council Recommendation of 2 December 2003 on cancer screening (2003/878/EC). Brussels

METODOLOGIE din 28 iunie 2024 (2024) [Corola-llms4eu/Law/285272]
infections and type specific implications in cervical neoplasia. Vaccine, vol. 26 Suppl 10, pp. K1-16 Commission of the European Communities (2008). Report from the Commission to the Council, the European Parliament, the European Economic and Social Committee and the Committee of the Regions - Implementation of the Council Recommendation of 2 December 2003 on cancer screening (2003/878/EC). Brussels, Report no. COM (2008) 882 final. Available from (accessed on 12/04/2015): http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=COM:2008:0882:FIN:EN:PDF Gök M, van Kemenade FJ, Heideman DA, Berkhof J, Rozendaal L, Spruyt

METODOLOGIE din 28 iunie 2024 (2024) [Corola-llms4eu/Law/285272]
implications in cervical neoplasia. Vaccine, vol. 26 Suppl 10, pp. K1-16 Commission of the European Communities (2008). Report from the Commission to the Council, the European Parliament, the European Economic and Social Committee and the Committee of the Regions - Implementation of the Council Recommendation of 2 December 2003 on cancer screening (2003/878/EC). Brussels, Report no. COM (2008) 882 final. Available from (accessed on 12/04/2015): http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=COM:2008:0882:FIN:EN:PDF Gök M, van Kemenade FJ, Heideman DA, Berkhof J, Rozendaal L, Spruyt JW, Beliën JA, Babovic

METODOLOGIE din 28 iunie 2024 (2024) [Corola-llms4eu/Law/285272]
Vaccine, vol. 26 Suppl 10, pp. K1-16 Commission of the European Communities (2008). Report from the Commission to the Council, the European Parliament, the European Economic and Social Committee and the Committee of the Regions - Implementation of the Council Recommendation of 2 December 2003 on cancer screening (2003/878/EC). Brussels, Report no. COM (2008) 882 final. Available from (accessed on 12/04/2015): http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=COM:2008:0882:FIN:EN:PDF Gök M, van Kemenade FJ, Heideman DA, Berkhof J, Rozendaal L, Spruyt JW, Beliën JA, Babovic M, Snijders PJ & Meijer

METODOLOGIE din 28 iunie 2024 (2024) [Corola-llms4eu/Law/285272]
882 final. Available from (accessed on 12/04/2015): http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=COM:2008:0882:FIN:EN:PDF Gök M, van Kemenade FJ, Heideman DA, Berkhof J, Rozendaal L, Spruyt JW, Beliën JA, Babovic M, Snijders PJ & Meijer CJ (2012). Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program. Int J Cancer, Mar 1;130(5):1128-35. doi:10.1002/ijc.26128. Epub 2011 May 30 IARC (2005). Cervix Cancer Screening. IARC Handbooks of Cancer Prevention. Vol. 10. IARC Press, Lyon. 133Kaplan JE, Benson C, Holmes KK, Brooks

METODOLOGIE din 28 iunie 2024 (2024) [Corola-llms4eu/Law/285272]
Available from (accessed on 12/04/2015): http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=COM:2008:0882:FIN:EN:PDF Gök M, van Kemenade FJ, Heideman DA, Berkhof J, Rozendaal L, Spruyt JW, Beliën JA, Babovic M, Snijders PJ & Meijer CJ (2012). Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program. Int J Cancer, Mar 1;130(5):1128-35. doi:10.1002/ijc.26128. Epub 2011 May 30 IARC (2005). Cervix Cancer Screening. IARC Handbooks of Cancer Prevention. Vol. 10. IARC Press, Lyon. 133Kaplan JE, Benson C, Holmes KK, Brooks JT, Pau

METODOLOGIE din 28 iunie 2024 (2024) [Corola-llms4eu/Law/285272]
PJ & Meijer CJ (2012). Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program. Int J Cancer, Mar 1;130(5):1128-35. doi:10.1002/ijc.26128. Epub 2011 May 30 IARC (2005). Cervix Cancer Screening. IARC Handbooks of Cancer Prevention. Vol. 10. IARC Press, Lyon. 133Kaplan JE, Benson C, Holmes KK, Brooks JT, Pau A & Masur H (2009). Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Kiviat NB, Hawes SE & Feng Q

METODOLOGIE din 28 iunie 2024 (2024) [Corola-llms4eu/Law/285272]
130(5):1128-35. doi:10.1002/ijc.26128. Epub 2011 May 30 IARC (2005). Cervix Cancer Screening. IARC Handbooks of Cancer Prevention. Vol. 10. IARC Press, Lyon. 133Kaplan JE, Benson C, Holmes KK, Brooks JT, Pau A & Masur H (2009). Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Kiviat NB, Hawes SE & Feng Q (2008). Screening for cervical cancer in the era of the HPV vaccine - the urgent need for both new screening guidelines and new biomarkers. J Natl Cancer

METODOLOGIE din 28 iunie 2024 (2024) [Corola-llms4eu/Law/285272]
2009). Cervical intraepithelial neoplasia recurrence after conization in HIV-positive and HIV-negative women. Int J Gynaecol Obstet., vol. 104, no. 2, pp. 100-104 Lynge E, Anttila A, Arbyn M, Segnan N & Ronco G (2009). Wha’s next? Perspectives and future needs of cervical screening in Europe in the era of molecular testing and vaccination, Eur J Cancer, vol. 45, no. 15, pp. 2714-2721 Meijer CJ, Berkhof J, Heideman DA & Snijders PJ (2008). Cervical cancer prevention: who should receive vaccination? Nat Clin Pract

METODOLOGIE din 28 iunie 2024 (2024) [Corola-llms4eu/Law/285272]
HIV-positive and HIV-negative women. Int J Gynaecol Obstet., vol. 104, no. 2, pp. 100-104 Lynge E, Anttila A, Arbyn M, Segnan N & Ronco G (2009). Wha’s next? Perspectives and future needs of cervical screening in Europe in the era of molecular testing and vaccination, Eur J Cancer, vol. 45, no. 15, pp. 2714-2721 Meijer CJ, Berkhof J, Heideman DA & Snijders PJ (2008). Cervical cancer prevention: who should receive vaccination? Nat Clin Pract Oncol, vol. 5, no. 1, pp. 12-13 Public

METODOLOGIE din 28 iunie 2024 (2024) [Corola-llms4eu/Law/285272]
09/03/2015): http://www.cancerscreening.nhs.uk/cervical/hpv-primary-screening.html Ronco G, van Ballegooijen M, Becker N, Chil A, Fender M, Giubilato P, Kurtinaitis J, Lancucki L, Lynge E, Morais A, O’Reilly M, Sparen P, Suteu O, Rebolj M, Veerus P, Zakelj MP & Anttila A (2009). Process performance of cervical screening programmes in Europe. Eur J Cancer, vol. 45, no. 15, pp. 2659-2670 Ronco G, von Karsa L & Anttila A (2008). Key performance indicators. In: European guidelines for quality assurance in cervical cancer screening - second edition, Arbyn M, Anttila

METODOLOGIE din 28 iunie 2024 (2024) [Corola-llms4eu/Law/285272]
2008). Key performance indicators. In: European guidelines for quality assurance in cervical cancer screening - second edition, Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Wiener H, Herbert A, Daniel J, & von Karsa L (eds.). Office for Official Publications of the European Communities, Luxembourg, pp. 231-242 Spitzer M (1999). Lower genital tract intraepithelial neoplasia in HIV-infected women: guidelines for evaluation and management. Obstet Gynecol Surv, vol. 54, no. 2, pp. 131-137 Torres-Mejia G, Salmeron-Castro J, Tellez-Rojo MM, Lazcano-Ponce EC

METODOLOGIE din 28 iunie 2024 (2024) [Corola-llms4eu/Law/285272]
reminders on cervical cancer screening: a meta-analysis. J Gen Intern Med, vol. 16, no. 8, pp. 563-568 von Karsa L, Anttila A, Primic Žakelj M, de Wolf C, Bielska-Lasota M, Törnberg S & Segnan N (2013). Stockholm statement on successful implementation of population-based cancer screening programmes. Annex 1a. In: European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition, Supplements. Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, vonKarsa L (eds.). Office for Official Publications of

METODOLOGIE din 28 iunie 2024 (2024) [Corola-llms4eu/Law/285272]
of population-based cancer screening programmes. Annex 1a. In: European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition, Supplements. Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, vonKarsa L (eds.). Office for Official Publications of the European Union, Luxembourg, pp. 123-128. Available from (accessed 12/04/2015): http://bookshop.europa.eu/en/european-guidelines-for-qualityassurance-in-breast-cancer-screening-and-diagnosis-pbND0213386/ von Karsa L, Dean PB, Arrossi S & Sankaranarayanan R. (2014a). Screening - principles. Chapter 4.7. In: World Cancer Report 2014, Stewart BW, Wild CP (eds.). International Agency for Research on

METODOLOGIE din 28 iunie 2024 (2024) [Corola-llms4eu/Law/285272]